| Year |
Citation |
Score |
| 2022 |
Snider NT, Hollenberg PF. Assay of Endocannabinoid Oxidation by Cytochrome P450. Methods in Molecular Biology (Clifton, N.J.). 2576: 317-327. PMID 36152199 DOI: 10.1007/978-1-0716-2728-0_27 |
0.574 |
|
| 2018 |
Battaglia RA, Delic S, Herrmann H, Snider NT. Vimentin on the move: new developments in cell migration. F1000research. 7. PMID 30505430 DOI: 10.12688/F1000Research.15967.1 |
0.302 |
|
| 2017 |
Battaglia RA, Kabiraj P, Willcockson HH, Lian M, Snider NT. Isolation of Intermediate Filament Proteins from Multiple Mouse Tissues to Study Aging-associated Post-translational Modifications. Journal of Visualized Experiments : Jove. PMID 28570536 DOI: 10.3791/55655 |
0.361 |
|
| 2016 |
Snider NT, Portney DA, Willcockson HH, Maitra D, Martin HC, Greenson JK, Omary MB. Ethanol and Acetaminophen Synergistically Induce Hepatic Aggregation and TCH346-Insensitive Nuclear Translocation of GAPDH. Plos One. 11: e0160982. PMID 27513663 DOI: 10.1371/Journal.Pone.0160982 |
0.342 |
|
| 2016 |
Snider NT, Walker VJ, Hollenberg PF. Assay of Endocannabinoid Oxidation by Cytochrome P450. Methods in Molecular Biology (Clifton, N.J.). 1412: 227-36. PMID 27245908 DOI: 10.1007/978-1-4939-3539-0_23 |
0.606 |
|
| 2016 |
Snider NT. Kidney keratins: cytoskeletal stress responders with biomarker potential. Kidney International. 89: 738-40. PMID 26994569 DOI: 10.1016/J.Kint.2015.12.040 |
0.314 |
|
| 2015 |
Kwan R, Chen L, Looi K, Tao GZ, Weerasinghe SV, Snider NT, Conti MA, Adelstein RS, Xie Q, Omary MB. PKC412 normalizes mutation-related keratin filament disruption and hepatic injury in mice by promoting keratin-myosin binding. Hepatology (Baltimore, Md.). PMID 26126491 DOI: 10.1002/Hep.27965 |
0.346 |
|
| 2015 |
Snider NT, Altshuler PJ, Omary MB. Modulation of cytoskeletal dynamics by mammalian nucleoside diphosphate kinase (NDPK) proteins. Naunyn-Schmiedeberg's Archives of Pharmacology. 388: 189-97. PMID 25234227 DOI: 10.1007/S00210-014-1046-5 |
0.314 |
|
| 2015 |
Snider NT, Portney DA, Maitra D, Weerasinghe S, Omary MB. 280 TCH346 Targets Mitochondria and Protects in Combined Ethanol and Acetaminophen Mouse Liver Injury Independently of GAPDH Gastroenterology. 148: S-975. DOI: 10.1016/S0016-5085(15)33332-1 |
0.33 |
|
| 2014 |
Snider NT, Omary MB. Post-translational modifications of intermediate filament proteins: mechanisms and functions. Nature Reviews. Molecular Cell Biology. 15: 163-77. PMID 24556839 DOI: 10.1038/Nrm3753 |
0.312 |
|
| 2013 |
Snider NT, Griggs NW, Singla A, Moons DS, Weerasinghe SV, Lok AS, Ruan C, Burant CF, Conjeevaram HS, Omary MB. CD73 (ecto-5'-nucleotidase) hepatocyte levels differ across mouse strains and contribute to mallory-denk body formation. Hepatology (Baltimore, Md.). 58: 1790-800. PMID 23729294 DOI: 10.1002/Hep.26525 |
0.371 |
|
| 2013 |
Singla A, Griggs NW, Kwan R, Snider NT, Maitra D, Ernst SA, Herrmann H, Omary MB. Lamin aggregation is an early sensor of porphyria-induced liver injury. Journal of Cell Science. 126: 3105-12. PMID 23641075 DOI: 10.1242/Jcs.123026 |
0.384 |
|
| 2013 |
Snider NT, Leonard JM, Kwan R, Griggs NW, Rui L, Omary MB. Glucose and SIRT2 reciprocally mediate the regulation of keratin 8 by lysine acetylation. The Journal of Cell Biology. 200: 241-7. PMID 23358244 DOI: 10.1083/Jcb.201209028 |
0.306 |
|
| 2012 |
Singla A, Moons DS, Snider NT, Wagenmaker ER, Jayasundera VB, Omary MB. Oxidative stress, Nrf2 and keratin up-regulation associate with Mallory-Denk body formation in mouse erythropoietic protoporphyria. Hepatology (Baltimore, Md.). 56: 322-31. PMID 22334478 DOI: 10.1002/Hep.25664 |
0.335 |
|
| 2011 |
Snider NT, Weerasinghe SV, Singla A, Leonard JM, Hanada S, Andrews PC, Lok AS, Omary MB. Energy determinants GAPDH and NDPK act as genetic modifiers for hepatocyte inclusion formation. The Journal of Cell Biology. 195: 217-29. PMID 22006949 DOI: 10.1083/Jcb.201102142 |
0.407 |
|
| 2011 |
Sridar C, Snider NT, Hollenberg PF. Anandamide oxidation by wild-type and polymorphically expressed CYP2B6 and CYP2D6. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 39: 782-8. PMID 21289075 DOI: 10.1124/Dmd.110.036707 |
0.624 |
|
| 2011 |
Snider NT, Singla A, Weerasinghe S, Hanada S, Sun X, Andrews PC, Omary B. Compromised Energetics and Redox Cycling via GAPDH Underlie Genetic Predisposition to Hepatocyte Protein Aggregation During Liver Injury Gastroenterology. 140: S-905. DOI: 10.1016/S0016-5085(11)63757-8 |
0.356 |
|
| 2010 |
Pratt-Hyatt M, Zhang H, Snider NT, Hollenberg PF. Effects of a commonly occurring genetic polymorphism of human CYP3A4 (I118V) on the metabolism of anandamide. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 38: 2075-82. PMID 20702771 DOI: 10.1124/Dmd.110.033712 |
0.679 |
|
| 2010 |
Snider NT, Walker VJ, Hollenberg PF. Oxidation of the endogenous cannabinoid arachidonoyl ethanolamide by the cytochrome P450 monooxygenases: physiological and pharmacological implications. Pharmacological Reviews. 62: 136-54. PMID 20133390 DOI: 10.1124/Pr.109.001081 |
0.615 |
|
| 2010 |
Hanada S, Snider NT, Brunt EM, Hollenberg PF, Omary MB. Gender dimorphic formation of mouse Mallory-Denk bodies and the role of xenobiotic metabolism and oxidative stress. Gastroenterology. 138: 1607-17. PMID 20064513 DOI: 10.1053/J.Gastro.2009.12.055 |
0.58 |
|
| 2010 |
Snider NT, Pratt-Hyatt M, Looi K, Hollenberg PF, Omary B. 705 Dynamic SUMOylation of Keratins During Oxidative Liver Injury Gastroenterology. 138: S-795. DOI: 10.1016/S0016-5085(10)63663-3 |
0.653 |
|
| 2010 |
Snider NT, Hanada S, Weerasinghe S, Andrews PC, Omary B. M1994 Molecular Factors Involved in Determining Genetic Susceptibility to Mallory-Denk Body Formation Gastroenterology. 138: S-455. DOI: 10.1016/S0016-5085(10)62103-8 |
0.424 |
|
| 2009 |
Snider NT, Nast JA, Tesmer LA, Hollenberg PF. A cytochrome P450-derived epoxygenated metabolite of anandamide is a potent cannabinoid receptor 2-selective agonist. Molecular Pharmacology. 75: 965-72. PMID 19171674 DOI: 10.1124/Mol.108.053439 |
0.61 |
|
| 2008 |
Snider NT, Sikora MJ, Sridar C, Feuerstein TJ, Rae JM, Hollenberg PF. The endocannabinoid anandamide is a substrate for the human polymorphic cytochrome P450 2D6 Journal of Pharmacology and Experimental Therapeutics. 327: 538-545. PMID 18698000 DOI: 10.1124/Jpet.108.141796 |
0.607 |
|
| 2007 |
Snider NT, Kornilov AM, Kent UM, Hollenberg PF. Anandamide metabolism by human liver and kidney microsomal cytochrome p450 enzymes to form hydroxyeicosatetraenoic and epoxyeicosatrienoic acid ethanolamides. The Journal of Pharmacology and Experimental Therapeutics. 321: 590-7. PMID 17272674 DOI: 10.1124/Jpet.107.119321 |
0.639 |
|
| Show low-probability matches. |